
Anne Gussow
Supervisory Patent Examiner (ID: 18283, Phone: (571)272-6047 , Office: P/1636 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1683, 1600, 1636, 1643 |
| Total Applications | 445 |
| Issued Applications | 202 |
| Pending Applications | 78 |
| Abandoned Applications | 174 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10256277
[patent_doc_number] => 20150141274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'Methods and Compositions for Activity Dependent Transcriptome Profiling'
[patent_app_type] => utility
[patent_app_number] => 14/399057
[patent_app_country] => US
[patent_app_date] => 2013-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 38541
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399057
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399057 | Methods and Compositions for Activity Dependent Transcriptome Profiling | May 8, 2013 | Abandoned |
Array
(
[id] => 10437426
[patent_doc_number] => 20150322439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'REPLICATIVE MINICIRCLE VECTORS WITH IMPROVED EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 14/442862
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21226
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442862
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442862 | REPLICATIVE MINICIRCLE VECTORS WITH IMPROVED EXPRESSION | Mar 13, 2013 | Abandoned |
Array
(
[id] => 8814611
[patent_doc_number] => 20130115656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'ENGINEERED YEAST CELLS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/665149
[patent_app_country] => US
[patent_app_date] => 2012-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12262
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13665149
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/665149 | ENGINEERED YEAST CELLS AND USES THEREOF | Oct 30, 2012 | Abandoned |
Array
(
[id] => 8370623
[patent_doc_number] => 20120220011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'UNSTRUCTURED RECOMBINANT POLYMERS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/396403
[patent_app_country] => US
[patent_app_date] => 2012-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 49568
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13396403
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/396403 | UNSTRUCTURED RECOMBINANT POLYMERS AND USES THEREOF | Feb 13, 2012 | Abandoned |
Array
(
[id] => 8301896
[patent_doc_number] => 20120184453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'BIOMARKERS FOR RECURRENCE PREDICTION OF COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/348098
[patent_app_country] => US
[patent_app_date] => 2012-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 12749
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13348098
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/348098 | BIOMARKERS FOR RECURRENCE PREDICTION OF COLORECTAL CANCER | Jan 10, 2012 | Abandoned |
Array
(
[id] => 8335549
[patent_doc_number] => 20120202251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'IN VIVO ASSEMBLY OF DNA VIA HOMOLOGOUS RECOMBINATION'
[patent_app_type] => utility
[patent_app_number] => 13/282195
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16193
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13282195
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/282195 | IN VIVO ASSEMBLY OF DNA VIA HOMOLOGOUS RECOMBINATION | Oct 25, 2011 | Abandoned |
Array
(
[id] => 8055921
[patent_doc_number] => 20120077707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'MICROWELLS WITH MRI READABLE INDICIA'
[patent_app_type] => utility
[patent_app_number] => 13/241336
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1808
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077707.pdf
[firstpage_image] =>[orig_patent_app_number] => 13241336
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/241336 | MICROWELLS WITH MRI READABLE INDICIA | Sep 22, 2011 | Abandoned |
Array
(
[id] => 7651789
[patent_doc_number] => 20110301058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => ' MICROFLUIDIC DEVICE'
[patent_app_type] => utility
[patent_app_number] => 13/156250
[patent_app_country] => US
[patent_app_date] => 2011-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5920
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301058.pdf
[firstpage_image] =>[orig_patent_app_number] => 13156250
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/156250 | MICROFLUIDIC DEVICE | Jun 7, 2011 | Abandoned |
Array
(
[id] => 8442257
[patent_doc_number] => 20120258873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'REDUCTION OF 2,3-DIHYDROXY-2-METHYL BUTYRATE (DHMB) IN BUTANOL PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 13/153866
[patent_app_country] => US
[patent_app_date] => 2011-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 34697
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13153866
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/153866 | REDUCTION OF 2,3-DIHYDROXY-2-METHYL BUTYRATE (DHMB) IN BUTANOL PRODUCTION | Jun 5, 2011 | Abandoned |
Array
(
[id] => 12326895
[patent_doc_number] => 09944951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Chromosome 3p21.3 genes are tumor suppressors
[patent_app_type] => utility
[patent_app_number] => 13/114921
[patent_app_country] => US
[patent_app_date] => 2011-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 89
[patent_no_of_words] => 45612
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13114921
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/114921 | Chromosome 3p21.3 genes are tumor suppressors | May 23, 2011 | Issued |
Array
(
[id] => 8397934
[patent_doc_number] => 08268309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Compositions and methods for the therapy and diagnosis of cytomegalovirus'
[patent_app_type] => utility
[patent_app_number] => 13/109632
[patent_app_country] => US
[patent_app_date] => 2011-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 35638
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13109632
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/109632 | Compositions and methods for the therapy and diagnosis of cytomegalovirus | May 16, 2011 | Issued |
Array
(
[id] => 7586838
[patent_doc_number] => 20110281348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'AGONIST ANTI-TRKC ANTIBODIES AND METHODS USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/107861
[patent_app_country] => US
[patent_app_date] => 2011-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29650
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281348.pdf
[firstpage_image] =>[orig_patent_app_number] => 13107861
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/107861 | AGONIST ANTI-TRKC ANTIBODIES AND METHODS USING SAME | May 12, 2011 | Abandoned |
Array
(
[id] => 7711015
[patent_doc_number] => 20120003671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'METHODS FOR ANTIBODY ENGINEERING'
[patent_app_type] => utility
[patent_app_number] => 13/100089
[patent_app_country] => US
[patent_app_date] => 2011-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15625
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13100089
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/100089 | Methods for antibody engineering | May 2, 2011 | Issued |
| 13/086897 | LeY SPECIFIC BIOTHERAPEUTIC | Apr 13, 2011 | Abandoned |
Array
(
[id] => 7491009
[patent_doc_number] => 20110237780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'ANTI-INFLAMMATORY DAB'
[patent_app_type] => utility
[patent_app_number] => 13/008342
[patent_app_country] => US
[patent_app_date] => 2011-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7310
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237780.pdf
[firstpage_image] =>[orig_patent_app_number] => 13008342
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/008342 | Anti-inflammatory dAb | Jan 17, 2011 | Issued |
Array
(
[id] => 7586382
[patent_doc_number] => 20110280892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/974953
[patent_app_country] => US
[patent_app_date] => 2010-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 71
[patent_no_of_words] => 64907
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20110280892.pdf
[firstpage_image] =>[orig_patent_app_number] => 12974953
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/974953 | TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES | Dec 20, 2010 | Abandoned |
Array
(
[id] => 8347793
[patent_doc_number] => 20120208718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'SCHIZOPHRENIA TREATMENT RESPONSE BIOMARKERS'
[patent_app_type] => utility
[patent_app_number] => 13/499672
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10918
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499672
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/499672 | SCHIZOPHRENIA TREATMENT RESPONSE BIOMARKERS | Sep 30, 2010 | Abandoned |
Array
(
[id] => 6202399
[patent_doc_number] => 20110065185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'MUTATED ANTI-CD22 ANTIBODIES WITH INCREASED AFFINITY TO CD22-EXPRESSING LEUKEMIA CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/846625
[patent_app_country] => US
[patent_app_date] => 2010-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19514
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065185.pdf
[firstpage_image] =>[orig_patent_app_number] => 12846625
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/846625 | MUTATED ANTI-CD22 ANTIBODIES WITH INCREASED AFFINITY TO CD22-EXPRESSING LEUKEMIA CELLS | Jul 28, 2010 | Abandoned |
Array
(
[id] => 6268336
[patent_doc_number] => 20100298544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'CDR-GRAFTED ANTI-TISSUE FACTOR ANTIBODIES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/797737
[patent_app_country] => US
[patent_app_date] => 2010-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 12792
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12797737
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/797737 | CDR-GRAFTED ANTI-TISSUE FACTOR ANTIBODIES AND METHODS OF USE THEREOF | Jun 9, 2010 | Abandoned |
Array
(
[id] => 8571928
[patent_doc_number] => 08338576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Antibodies specific for DKK-1 and their uses'
[patent_app_type] => utility
[patent_app_number] => 12/777806
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 24
[patent_no_of_words] => 56498
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12777806
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/777806 | Antibodies specific for DKK-1 and their uses | May 10, 2010 | Issued |